Back to Top Skip to main content

Deputy defense secretary stresses team approach in battling COVID

Soldier wearing mask, standing at computer monitors in an office building Army Maj. Nicholas Gauvin works inside Operation Warp Speed headquarters in Washington, D.C., last month. (Photo by EJ Hersom, DOD.)

Recommended Content:

MHS Transformation | Coronavirus | COVID-19 Vaccine Efforts | Health Readiness | COVID-19 Vaccine Toolkit

Deputy Secretary of Defense David Norquist emphasized a years-long reform of the Military Health System while praising the short-term effort of private industry, other government agencies, and the MHS working together toward a COVID-19 vaccine goal in his speech this week at the virtual 2020 annual meeting of AMSUS, the Society of Federal Health Professionals.

In his address, “The National Defense Strategy in 2020,” Norquist said while the general news of the COVID-19 vaccines in development and testing have been in the news for the past month or so, what we’re really seeing has been ongoing for 2020 — and even well before.

Norquist said that careful planning, correct execution, and making sure the vaccines are safe, effective, and follow the Centers for Disease Control and Prevention standards are crucial, whether in another pandemic or a different crisis.

Early on, leaders need to say, “what do we need to be as the end solution, not just the response to today, and how do I put in place a team to do that?” Norquist said.

Focusing solely on that long-term solution is what MHS has done with the Department of Health and Human Services and Operation Warp Speed, he emphasized.

Image of Deputy Secretary Norquist
Deputy Secretary of Defense David Norquist praised the operation during his speech to the 2020 Annual Meeting of AMSUS. (Photo by EJ Hersom, DOD.)

The Military Health System has played an important role implementing the National Defense Strategy, Norquist said. By undertaking critical reforms, the MHS is working on fulfilling the strategy’s first line of effort: to build a more lethal and ready force.

The MHS is one of the largest DOD programs, with a budget of more than $50 billion each year, and “warrants extra attention,” Norquist said.

In 2017, Congress directed the largest health care system reform in over a generation, recognizing the need to reform the military medical force and military medical treatment facilities.

“We need personnel with the right specialties to treat patients on and off the battlefield,” Norquist said. “Congress recognized that we were short on critical wartime specialties. Many of our military medical personnel provide services that are similar to the private sector. But we have fewer prepared to meet warfighter needs. As a result, Congress mandated DOD to rethink how we organize, train, and equip our medical force.

“Our goal is to achieve and sustain an appropriate specialty mix,” Norquist added. “While beneficiary care will always be important, Congress recognized the DOD needs to lead in the area it knows best. This change will save lives. The second major change concerns our [military medical treatment facilities]. This reform is related to the first, and it addresses efficiency in one of the largest cost drivers of the Military Health System. Congress directed us to transfer control of [military medical treatment facilities] from the services to the Defense Health Agency.”

Consolidating beneficiary care to the Defense Health Agency and focusing the service surgeons general on readiness removes risk, Norquist said, and leads to greater efficiencies and lower costs.

“Of course, I’d be remiss if I did not mention our progress on Operation Warp Speed, a joint effort with HHS to deliver safe and effective vaccines, therapeutics, and diagnostics in record time,” he added.

“Operation Warp Speed will enable immediate large-scale delivery of millions of doses, something only possible because production is already ongoing,” Norquist said, underscoring military readiness well before the vaccines were fully developed.

You also may be interested in...

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

Continuing Implementation of the Reform of the Military Health System

Policy

This memorandum directs the continued implementation of the Military Health System (MHS) organizational reform required by 10 U.S.C. § 1073c, and sections 71 land 712 of the John S. McCain National Defense Authorization Act (NDAA) for Fiscal Year (FY) 2019. The DoD policy for this reform is guided by the goals of improved readiness, better health, better care, and lower cost. The Department will advance these objectives through specific organizational reforms directed by Congress and the continued direction of the Secretary of Defense·anct the National Defense Strategy.

DHA IPM 19-003: Reserve Health Readiness Program

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (i): • Provides utilization guidance and funding requirements for the RHRP contract to supplement Reserve Component Individual Medical Readiness (IMR) and Deployment Health activities when Service organic health readiness resources are not available to meet mission requirements. • Provides utilization guidance and funding requirements for the RHRP contract for Active Duty enrolled in TRICARE Prime Remote, U.S. Coast Guard (USCG), USCG Reserves, and re-deploying DoD civilians (e.g., U.S. Army Corps of Engineers and U.S. Army Intelligence and Security Command). • Communicate procedure guidance to all DoD organizations utilizing RHRP services. • Will expire effective 12 months from the date of issue and be converted to a DHA-Procedural Instruction.

  • Identification #: 19-003
  • Date: 3/8/2019
  • Type: DHA Interim Procedures Memorandum
  • Topics: Health Readiness

DHA PI 6025.07: Naloxone in the MTFs

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (h), establishes the Defense Health Agency’s (DHA) procedures for prescribing and dispensing naloxone by pharmacists in MTFs to eligible beneficiaries, upon beneficiary request, or when the pharmacist determines the beneficiary meets the established criteria for being at risk for a life-threatening opiate overdose.

DHA PI 6200.05: Force Health Protection Quality Assurance (FHPQA) Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (ab), establishes the procedures for the FHPQA Program as defined in Reference (z). This DHA-PI applies to: a. OSD, the Military Departments (including the United States Coast Guard (USCG) at all times, including when it is a Service in the Department of Homeland Security by agreement with that Department), the Office of the Chairman of the Joint Chiefs of Staff (CJCS) and the Joint Staff, the Combatant Commands, the Office of the Inspector General of the DoD, the Defense Agencies, the DoD Field Activities, and all other organizational entities within the DoD (referred to collectively in this DHA-PI as the “DoD Components”). b. Civilian personnel, as defined in Reference (e), and DoD contractor personnel authorized to accompany the force (CAAF), in accordance with References (j), (m), and (n), respectively.

  • Identification #: DHA PI 6200.05
  • Date: 5/2/2018
  • Type: DHA Procedural Instruction
  • Topics: Health Readiness

DoD Instruction 6200.05: Force Health Protection Quality Assurance (FHPQA) Program

Policy

This issuance establishes policy, assigns responsibilities, and defines requirements for the development and establishment of the FHPQA Program in accordance with the authority in DoD Directive (DoDD) 5124.02, Sections 731 and 738 of Public Law 108-375; Sections 1074f, 1092a, and 1073b of Title 10, United States Code; and DoDDs 6200.04 and 5136.13.

<< < 1 2 3 > >> 
Showing results 1 - 15 Page 1 of 3

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.